ImmuCell Secures $2 Million Settlement Payment from Norbrook Laboratories
ICCC sits 83% above its 52-week low of $4.52.
Summary
ImmuCell Corporation announced a settlement deed with Norbrook Laboratories Limited, resulting in a $2 million payment to ImmuCell to resolve claims from a prior development and supply agreement.
Key Events · Financing and Capital Events · ICCC
-
Settlement Agreement Reached
ImmuCell Corporation entered into a Settlement Deed with Norbrook Laboratories Limited to resolve all claims arising from a 2019 Development Services and Commercial Supply Agreement.
-
$2 Million Cash Inflow
Under the terms of the Settlement Deed, Norbrook Laboratories has agreed to pay ImmuCell a sum of $2,000,000.
-
Resolution of Expired Agreement
The settlement finalizes matters related to the underlying agreement, which had previously expired on March 31, 2026.
Analysis · ICCC · Life Sciences
This 8-K filing reports a significant financial event for ImmuCell Corporation. The $2 million settlement payment from Norbrook Laboratories represents a substantial cash inflow for the company. This one-time payment resolves claims related to a previously expired development and supply agreement, providing a positive boost to the company's liquidity and balance sheet. Investors should view this as a favorable development, as it strengthens the company's financial position without incurring new debt or equity dilution.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICCC was trading at $8.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $72.8M. The 52-week trading range was $4.52 to $9.08. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.